Notably, loss of SDHB expression in metastatic tumors correlated with longer overall survival, suggesting that SDHB, combined with Ki-67%, may serve as a prognostic marker in metastatic SI-NETs (95). The gene discussed is SDHB; the disease is metastatic neoplasm.